Skip to main content

Intra-Cellular Therapies, Inc.

ITCIDelisted Apr 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001567514

Intra-Cellular Therapies, Inc. was delisted on Apr 2, 2025; its insiders filed their last Form 4 on Apr 2, 2025; 395 institutions reported holding it in 13F filings for Q1 2025, worth $13.6B in total; Soros Fund Management was the only superinvestor holding it.

13F holders, Q1 2022

Institutional positions in Intra-Cellular Therapies, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
241
+35 vs. Q4 2021
Shares held
80.8M
+11.9M (+17.2%) vs. Q4 2021
Total value
$4.94B
+$1.34B (+37.3%) vs. Q4 2021
New holders
66
90 more added
Sold out
31
64 more reduced

2 institutions that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ITCI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 241 institutions
Q1 2021: 170 institutionsQ2 2021: 187 institutionsQ3 2021: 181 institutionsQ4 2021: 208 institutionsQ1 2022: 241 institutionsQ2 2022: 266 institutionsQ3 2022: 274 institutionsQ4 2022: 283 institutionsQ1 2023: 274 institutionsQ2 2023: 288 institutionsQ3 2023: 294 institutionsQ4 2023: 335 institutionsQ1 2024: 346 institutionsQ2 2024: 376 institutionsQ3 2024: 356 institutionsQ4 2024: 387 institutionsQ1 2025: 395 institutionsQ2 2025: 4 institutionsQ3 2025: 1 institutionQ4 2025: 1 institutionQ1 2026: 1 institutionQ2 2026: 1 institution
Value heldQ1 2022: $4.94B
Q1 2021: $2.30BQ2 2021: $2.74BQ3 2021: $2.56BQ4 2021: $3.60BQ1 2022: $4.94BQ2 2022: $4.65BQ3 2022: $3.89BQ4 2022: $4.41BQ1 2023: $4.55BQ2 2023: $5.34BQ3 2023: $4.54BQ4 2023: $6.42BQ1 2024: $6.15BQ2 2024: $6.62BQ3 2024: $7.12BQ4 2024: $8.08BQ1 2025: $13.6BQ2 2025: $4.15MQ3 2025: $2.54KQ4 2025: $2.54KQ1 2026: $2.54KQ2 2026: $2.54K
Institutions holding ITCI and their total value by quarter
QuarterHoldersValue
Q2 20261$2.54K
Q1 20261$2.54K
Q4 20251$2.54K
Q3 20251$2.54K
Q2 20254$4.15M
Q1 2025395$13.6B
Q4 2024387$8.08B
Q3 2024356$7.12B
Q2 2024376$6.62B
Q1 2024346$6.15B
Q4 2023335$6.42B
Q3 2023294$4.54B
Q2 2023288$5.34B
Q1 2023274$4.55B
Q4 2022283$4.41B
Q3 2022274$3.89B
Q2 2022266$4.65B
Q1 2022241$4.94B
Q4 2021208$3.60B
Q3 2021181$2.56B
Q2 2021187$2.74B
Q1 2021170$2.30B

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Intra-Cellular Therapies, Inc.; share changes are against Q4 2021.

Institutions holding ITCI in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Russell Investments Group, Ltd.444,375$27.2M0.05%+61,756+16.1%Added
Macquarie Group Ltd452,172$27.7M0.03%+731+0.2%Added
Bank of Montreal467,397$28.3M0.02%+178,420+61.7%Added
Invesco Ltd.478,385$29.3M0.01%+445,945+1,374.7%Added
Goldman Sachs Group Inc478,718$29.3M0.01%+243,475+103.5%Added
Samlyn Capital, LLC484,103$29.6M0.45%−625,752−56.4%Reduced
Driehaus Capital Management LLC488,460$29.9M0.37%+488,460New
Hood River Capital Management LLC510,830$31.3M1.04%+510,830New
Deutsche Bank AG512,304$31.3M0.01%−2,996−0.6%Reduced
Polar Capital Holdings Plc521,443$31.9M0.19%+429,708+468.4%Added
GW&K Investment Management, LLC549,327$33.6M0.30%+176,007+47.1%Added
Nicholas Investment Partners, LP562,373$34.4M2.45%−90,513−13.9%Reduced
Brandywine Global Investment Management, LLC568,811$34.8M0.25%−6,167−1.1%Reduced
Citadel Advisors LLC599,032$36.7M0.04%−151,684−20.2%Reduced
Charles Schwab Investment Management Inc607,737$37.2M0.01%+89,260+17.2%Added
Norges Bank637,942$39.0M0.01%+54,735+9.4%Added
Morgan Stanley653,984$40.0M0.01%−40,914−5.9%Reduced
Tang Capital Management LLC700,000$42.8M8.67%+700,000New
Holocene Advisors, LP722,724$44.2M0.23%+722,724New
Millennium Management LLC725,469$44.4M0.05%+92,312+14.6%Added
Nuveen Asset Management, LLC757,860$44.4M0.01%+123,973+19.6%Added
Dimensional Fund Advisors LP744,880$45.6M0.01%−44,939−5.7%Reduced
Adage Capital Partners GP, L.L.C.850,000$52.0M0.10%+600,000+240.0%Added
Northern Trust Corp873,978$53.5M0.01%+61,392+7.6%Added
TimesSquare Capital Management, LLC877,028$53.7M0.60%−466,937−34.7%Reduced
Victory Capital Management Inc932,322$56.9M0.06%+932,322New
Schroder Investment Management Group983,913$59.4M0.08%−195,926−16.6%Reduced
Geode Capital Management, LLC1,470,957$90.0M0.01%+185,143+14.4%Added
Pictet Asset Management SA1,485,488$90.9M0.10%+30,614+2.1%Added
Suvretta Capital Management, LLC1,531,923$93.7M2.86%+279,977+22.4%Added
Franklin Resources Inc1,698,696$103.9M0.04%+612,014+56.3%Added
State Street Corp1,792,530$109.7M0.01%+269,892+17.7%Added
Lord, Abbett & Co. LLC1,981,356$121.2M0.32%−149,464−7.0%Reduced
Marshall Wace, LLP2,519,764$154.2M0.32%+131,470+5.5%Added
Bellevue Group AG3,429,619$209.9M2.44%−199,300−5.5%Reduced
Wellington Management Group LLP4,061,160$248.5M0.04%+4,061,160New
BlackRock Inc.6,470,417$395.9M0.01%+748,651+13.1%Added
Wasatch Advisors Inc7,477,868$457.6M2.25%−757,303−9.2%Reduced
Vanguard Group Inc7,788,469$476.6M0.01%+912,268+13.3%Added
FMR LLC10,954,710$670.3M0.05%−7,259−0.1%Reduced
International Biotechnology Trust PLC50,956––−62,500−55.1%Reduced
Two Sigma Investments, LP0$00.00%−277,359−100.0%Sold out
Eversept Partners, LP0$00.00%−231,787−100.0%Sold out
Vantage Consulting Group Inc0$00.00%−226,670−100.0%Sold out
Altrinsic Global Advisors LLC0$00.00%−80,000−100.0%Sold out
Cooper/Haims Advisors, LLC0$00.00%−61,116−100.0%Sold out
Sofinnova Investments, Inc.0$00.00%−56,915−100.0%Sold out
Ergoteles LLC0$00.00%−53,656−100.0%Sold out
Tri Locum Partners LP0$00.00%−26,177−100.0%Sold out
Rock Creek Group, LP0$00.00%−27,543−100.0%Sold out
Kiwi Wealth Investments Limited Partnership0$00.00%−20,388−100.0%Sold out
EMC Capital Management0$00.00%−19,698−100.0%Sold out
Caption Management, LLC0$00.00%−17,144−100.0%Sold out
Quantbot Technologies LP0$00.00%−11,554−100.0%Sold out
Two Sigma Advisers, LP0$00.00%−11,467−100.0%Sold out
Group One Trading, L.P.0$00.00%−9,541−100.0%Sold out
Two Sigma Securities, LLC0$00.00%−8,779−100.0%Sold out
Avestar Capital, LLC0$00.00%−8,600−100.0%Sold out
J. Goldman & Co LP0$00.00%−7,585−100.0%Sold out
Kestra Advisory Services, LLC0$00.00%−6,045−100.0%Sold out
Squarepoint Ops LLC0$00.00%−5,815−100.0%Sold out
Wolverine Trading, LLC0$00.00%−5,445−100.0%Sold out
AlphaCrest Capital Management LLC0$00.00%−4,600−100.0%Sold out
XTX Topco Ltd0$00.00%−4,031−100.0%Sold out
Healthcare of Ontario Pension Plan Trust Fund0$00.00%−655−100.0%Sold out
Cambridge Trust Co0$00.00%−500−100.0%Sold out
Eaton Vance Management0$00.00%−500−100.0%Sold out
Confluence Wealth Services, Inc.0$00.00%−192−100.0%Sold out
Truvestments Capital LLC0$00.00%−148−100.0%Sold out
Laurel Wealth Advisors LLC0$00.00%−150−100.0%Sold out
First Horizon Advisors, Inc.0$00.00%−161−100.0%Sold out
Northwestern Mutual Wealth Management Co0$00.00%−10−100.0%Sold out
First Midwest Bank Trust Division––––Not filed
Bell Investment Advisors, Inc––––Not filed